ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ARWR Filings
Filing Date
Form Description
Form Type
2026-02-05
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2026 Earnings Call Transcript
Earnings Call
2026-02-05 · Earnings Call
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2026 Earnings Call Transcript
2026-02-05
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-05 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-05
Form 8-K - Current report
Key Events
2026-02-05 · Key Events
Form 8-K - Current report
2026-01-27
Form ARS - Annual Report to Security Holders
2026-01-27 ·
Form ARS - Annual Report to Security Holders
2026-01-27
Form DEF 14A - Other definitive proxy statements
Key Events
2026-01-27 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-27
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2026-01-27 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2026-01-09
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-09 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-09
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-09 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
